SciSparc (SPRC) Assets Average (2017 - 2025)
SciSparc (SPRC) posted Assets Average of $6.4 million for Q4 2025, down 17.6% sequentially from $7.7 million in Q2 2025, and down 38.73% YoY from $10.4 million in Q4 2024.
SciSparc (SPRC) Assets Average (2017 - 2025) Analysis & Trends
SciSparc has reported Assets Average for 9 years, with the latest figure at $6.4 million in Q4 2025.
- Quarterly Assets Average fell 38.73% year-over-year to $6.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.4 million (down 38.73% YoY) and the FY2025 annual result came in at $9.0 million, down 16.54% from the prior year.
- Assets Average fell to $6.4 million in Q4 2025 per SPRC's latest filing, from $7.7 million in the prior quarter.
- Over five years, Assets Average peaked at $14.3 million in Q3 2022 and troughed at $5.5 million in Q2 2021.
- A 5-year average of $10.0 million and a median of $10.4 million in 2024 frame the typical range for Assets Average.
- The sharpest annual moves came in 2021 and 2025: Assets Average surged 339.53% in 2021, then plunged 38.73% in 2025.
- Over 5 years, Assets Average stood at $9.1 million in 2021, then soared by 35.34% to $12.4 million in 2022, then fell by 14.71% to $10.5 million in 2023, then decreased by 1.16% to $10.4 million in 2024, then plunged by 38.73% to $6.4 million in 2025.
- According to Business Quant data, Assets Average over the past three periods registered $6.4 million, $7.7 million, and $10.4 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.34 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.09 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.27 Bn |
| 10 | SciSparc | 836,385.99 | 836,385.99 | - | 6.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.38 Mn |
| Jun 30, 2025 | 7.74 Mn |
| Dec 31, 2024 | 10.41 Mn |
| Jun 30, 2024 | 10.83 Mn |
| Dec 31, 2023 | 10.54 Mn |
| Jun 30, 2023 | 10.25 Mn |
| Dec 31, 2022 | 12.36 Mn |
| Sep 30, 2022 | 14.26 Mn |
| Jun 30, 2022 | 12.17 Mn |
| Dec 31, 2021 | 9.13 Mn |
| Jun 30, 2021 | 5.45 Mn |
| Dec 31, 2020 | 2.08 Mn |
| Jun 30, 2020 | 1.37 Mn |
| Dec 31, 2019 | 1.62 Mn |
| Jun 30, 2019 | 3.32 Mn |
| Mar 31, 2019 | 4.56 Mn |
| Jun 30, 2018 | 7.22 Mn |
| Mar 31, 2018 | 8.81 Mn |
| Dec 31, 2017 | 10.28 Mn |
| Sep 30, 2017 | 11.52 Mn |